IP Library Granted Patent US 8,912,362
Granted Patent B2
US 8,912,362 · App. 13/750,617 · Granted Dec 16, 2014

Synthesis of triethylenetetramines

Inventors: Marco Jonas (Neuenhof, CH); Irene Vaulont (Buchs, CH); Antonio Soi (Buchs, CH); Gunther Schmidt (Aarau, CH)
Assignee: Philera New Zealand Limited
C07C211/13C07C57/15C07B2200/13C07C209/48C07D233/26C07C211/10C07C209/62C07D233/02C07C55/10C07C211/14C07C57/145
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,912,362
App. No.
13/750,617
Granted
Dec 16, 2014
Kind
B2
Abstract

Methods and intermediates for synthesizing triethylenetetramine and salts thereof, as well as novel triethylenetetramine salts and their crystal structure, and triethylenetetramine salts of high purity.

Claims (15)

1. An isolated triethylenetetramine hydrochloride salt that has a purity of greater than about 95% pure.

2. The isolated triethylenetetramine hydrochloride salt of claim 1 wherein the salt is a triethylenetetramine dihydrochloride salt.

3. The isolated triethylenetetramine hydrochloride salt of claim 1 that has a purity of greater than about 96% pure.

4. The isolated triethylenetetramine hydrochloride salt of claim 3 wherein the salt is a triethylenetetramine dihydrochloride salt.

5. The isolated triethylenetetramine hydrochloride salt of claim 1 that has a purity of greater than about 97% pure.

6. The isolated triethylenetetramine hydrochloride salt of claim 5 wherein the salt is a triethylenetetramine dihydrochloride salt.

7. The isolated triethylenetetramine hydrochloride salt of claim 1 that has a purity of greater than about 98% pure.

8. The isolated triethylenetetramine hydrochloride salt of claim 7 wherein the salt is a triethylenetetramine dihydrochloride salt.

9. The isolated triethylenetetramine hydrochloride salt of claim 1 that has a purity of greater than about 99% pure.

10. The isolated triethylenetetramine hydrochloride salt of claim 9 wherein the salt is a triethylenetetramine dihydrochloride salt.

11. The isolated triethylenetetramine hydrochloride salt of claim 1 that has a purity of about 100% pure.

12. The isolated triethylenetetramine hydrochloride salt of claim 11 wherein the salt is a triethylenetetramine dihydrochloride salt.

13. A pharmaceutical composition comprising triethylenetetramine dihydrochloride having less than 5% impurities and a pharmaceutically acceptable excipient.

14. The pharmaceutical composition of claim 13 wherein the triethylenetetramine dihydrochloride has a purity of greater than about 95% pure.

15. An isolated triethylenetetramine salt that has a purity of greater than about 99% pure and has less than 10 ppm of heavy metals as determined by USP <231> II.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2014
From: JONAS, MARCO; VAULONT, IRENE; SOI, ANTONIO; SCHMIDT, GUNTHER
To: PROTEMIX CORPORATION LIMITED
Reel/Frame 034068/0831 →
CHANGE OF NAME Recorded Oct 30, 2014
From: PROTEMIX CORPORATION LIMITED
To: PHILERA NEW ZEALAND LIMITED
Reel/Frame 034068/0866 →
Continuity (5)
Continuation 13269399 · Oct 7, 2011
Continuation 12460616 · Jul 21, 2009
Division 11184761 · Jul 19, 2005
Provisional Application 60589080 · Jul 19, 2004
Related Publication 20130345311A1 · Dec 26, 2013